ALAS-H Antibodies

Santa Cruz Biotechnology features a diverse variety of ALAS-H monoclonal antibodies for research focused on understanding aminolevulinate synthase H. ALAS-H monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ALAS-H, or aminolevulinate synthase H, is a key enzyme in the heme biosynthesis pathway, catalyzing the first step in the production of porphyrins. ALAS-H plays a crucial role in cellular metabolism and is essential for the synthesis of hemoglobin, myoglobin, and various cytochromes. Researchers investigating ALAS-H can utilize conjugated options with horseradish peroxidase (HRP), phycoerythrin (PE), or fluorescein isothiocyanate (FITC) for enhanced detection flexibility. Understanding the function and regulation of ALAS-H is vital for elucidating disorders related to heme metabolism and for developing therapeutic strategies. Ongoing research with ALAS-H monoclonal antibodies continues to reveal new insights into heme biosynthesis pathways and their impact on human health. Santa Cruz Biotechnology monoclonal antibodies for ALAS-H support researchers worldwide in advancing our understanding of heme metabolism and related diseases.